Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial

BACKGROUND: Optimal antimicrobial drug exposure in the lung is required for successful treatment outcomes for nosocomial pneumonia. Little is known about the intrapulmonary pharmacokinetics (PK) of meropenem when administered by continuous infusion (CI). The aim of this study was to evaluate the PK...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Crit Care
Main Authors: Benítez-Cano, Adela, Luque, Sonia, Sorlí, Luisa, Carazo, Jesús, Ramos, Isabel, Campillo, Nuria, Curull, Víctor, Sánchez-Font, Albert, Vilaplana, Carles, Horcajada, Juan P., Adalia, Ramón, Bermejo, Silvia, Samsó, Enric, Hope, William, Grau, Santiago
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026992/
https://ncbi.nlm.nih.gov/pubmed/32066497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-2763-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares